Manual action car 2023
Ended Awarded Last action
- Contract number
- W90VN623F5038
- Awardee
-
Seoul Clinical Laboratories UEI E961H2AE4AN5
- Awarding agency
-
RCO Osan 411th CSB
Expeditionary Contracting Command, Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 1% obligated
-
- $2,494.05 Current, with exercised options
- $250,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Pacific Air Forces Air Force, Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Pacific Air Forces (PACAF) to Seoul Clinical Laboratories, a for-profit organization based in South Korea. The $250,000 contract is for the provision of manual action car services for the federal government in 2023, with a period of performance through February 2026.
Seoul Clinical Laboratories is an experienced provider of clinical laboratory testing and diagnostic services to the U.S. Department of Defense, including COVID-19 testing, pathology, and routine medical support for military personnel stationed in South Korea. The company has held multiple prime contracts and subcontracts to deliver these services, leveraging its extensive capabilities as a "mega-reference laboratory" in the region. This award is not designated as a set-aside contract.
Additionally, Seoul Clinical Laboratories holds several significant indefinite delivery vehicles (IDVs) with the Department of Defense, including an $11.3 million single-award IDV with the Army Medical Command for COVID-19 testing, as well as a $250,000 multiple-award BPA with PACAF for pathology testing services. These contracts demonstrate the ongoing trust and reliance placed on Seoul Clinical Laboratories by U.S. military healthcare providers in South Korea.
Quick answers
Who was awarded contract W90VN623F5038?
W90VN623F5038 was awarded to Seoul Clinical Laboratories by RCO Osan 411th CSB (Expeditionary Contracting Command) on June 1, 2023.
How much is contract W90VN623F5038 worth?
The government has obligated $2,494 on W90VN623F5038. Its potential value, with all options, is $250,000.
Which agency awarded contract W90VN623F5038?
RCO Osan 411th CSB (Expeditionary Contracting Command) awarded W90VN623F5038, with funding from Pacific Air Forces (Air Force).
Is contract W90VN623F5038 an order under another contract?
Yes. W90VN623F5038 is a BPA call under W90VN621A0006, a blanket purchase agreement.
Was contract W90VN623F5038 competed?
The extent of competition for W90VN623F5038 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award